Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
All content for Brain Trash: Psychiatry from DSM to Dumpster Fire is the property of Maria Ingalla & Tabitha Arey and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
Send us questions here! RFK's proposed Autism Registry isn’t about public health—it’s about power. This week on Brain Trash, we dive into the controversial Autism Registry plan and what it means for neurodivergent communities. We discuss how data collection can be weaponized, why environmental blame narratives are harmful, and how this policy might impact access to services. We’re calling it what it is: a dangerous precedent. Hear the truth and download our free guide at paperflowerinstitute....
Brain Trash: Psychiatry from DSM to Dumpster Fire
Send us questions here! Are psychedelics the future of psychiatry—or just another wave of hype? In this episode, Maria and Tabitha sit down with John Greeley to break down what the research really says about psychedelics like psilocybin, MDMA, and ketamine. We cover safety, harm reduction, cultural concerns, and what clinicians and patients alike need to know. ✨ Learn about: The science behind psychedelics and the brainWhy harm reduction mattersHow providers can support patients using psyched...
